PMC:7228307 / 56847-57109 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1164","span":{"begin":127,"end":134},"obj":"Gene"},{"id":"1165","span":{"begin":162,"end":170},"obj":"Species"}],"attributes":[{"id":"A1164","pred":"tao:has_database_id","subj":"1164","obj":"Gene:2212"},{"id":"A1165","pred":"tao:has_database_id","subj":"1165","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T957","span":{"begin":73,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T958","span":{"begin":95,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T959","span":{"begin":127,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1164","span":{"begin":127,"end":134},"obj":"Gene"},{"id":"1165","span":{"begin":162,"end":170},"obj":"Species"}],"attributes":[{"id":"A1164","pred":"pubann:denotes","subj":"1164","obj":"Gene:2212"},{"id":"A1165","pred":"pubann:denotes","subj":"1165","obj":"Tax:9606"}],"text":"Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T316","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials."}

{"project":"LitCovid-sentences","denotations":[{"id":"T316","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials."}